Sort
11,323 grants matching “glioblastoma”
RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$458,810John H Sampson · Duke University · R01 · FY2011 · CA
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC
$458,690Kwon-Sik Park · University Of Virginia · U01 · FY2021 · CA
The role of Tumor associated macrophages in glioblastoma
$458,596Dolores Hambardzumyan · Emory University · R01 · FY2017 · NS
The role of Tumor associated macrophages in glioblastoma
$458,596Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS
The role of Tumor associated macrophages in glioblastoma
$458,596Dolores Hambardzumyan · Emory University · R01 · FY2018 · NS
Application of autobioluminescence toward continuous and real-time in vitro/in vivo pre-clinical brain imaging for disease therapeutics
$458,595Larry J. Millet · University Of Tennessee Knoxville · R15 · FY2021 · CA
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti
$458,156Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · P01 · FY2017 · CA
A microfluidic blood-based test to monitor treatment response in glioblastoma
$458,136Shannon L Stott · Massachusetts General Hospital · R01 · FY2022 · CA
Maximizing the efficacy of MDM2 inhibitor therapy for MDM2-amplified glioblastoma
$458,021Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2024 · CA
03 - Neuro-Oncology
$457,959Louis B Nabors · University Of Alabama At Birmingham · P30 · FY2025 · CA
Mechanisms of Biguanide Sensitivity in GBM
$457,943Biplab Dasgupta · Emory University · R01 · FY2024 · NS
Dosimetry, Physics & Modeling Core
$457,878Charles Limoli · University Of California-Irvine · P01 · FY2023 · CA
Retroviral Coded Functions
$457,856Maxine L Linial · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
Computational analysis of Human High Grade Gliomas
$457,788Antonio Iavarone · Columbia University Health Sciences · R01 · FY2013 · NS
Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy
$457,719John Martin Brown · Stanford University · R01 · FY2013 · CA
Evaluation of AZD9291 in Glioblastoma patients with activated EGFR
$457,460Madan M Kwatra · Duke University · UH2 · FY2015 · TR
Novel multipronged Immunovirotherapy Approach for GBM Treatment
$456,968Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2023 · CA
Therapeutic Targeting of WDR5 in the Glioblastoma Perivascular Niche
$456,585Christopher G Hubert · Case Western Reserve University · R01 · FY2025 · NS
Therapeutic Targeting of WDR5 in the Glioblastoma Perivascular Niche
$456,585Christopher G Hubert · Case Western Reserve University · R01 · FY2023 · NS
Leveraging Zika virus and the immune system to treat glioblastoma
$456,534Milan Girish Chheda · Washington University · R01 · FY2023 · NS
Synthesis and Study of Cyclotryptamine and Diketopiperazine Alkaloids
$456,265Mohammad Movassaghi · Massachusetts Institute Of Technology · R01 · FY2019 · GM
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC
$456,113Kwon-Sik Park · University Of Virginia · U01 · FY2018 · CA
Novel monoclonal antibody for single dose treatment of acute CNS injury
$456,047Anne-Marie Carbonell · Oncosynergy, Inc. · R41 · FY2019 · NS
Mechanisms of Biguanide Sensitivity in GBM
$455,864Biplab Dasgupta · Emory University · R01 · FY2025 · NS
Molecular Mechanisms of TRAF7 Mutant Aggressive Meningiomas
$455,587Murat Gunel · Yale University · R01 · FY2024 · NS